Keywords:
Cardiac, Cardiovascular system, CT, CAD, Calcifications / Calculi
Authors:
A. J. Vázquez Mézquita, R. Choza Chenhalls, M. A. Teliz Meneses, N. B. Guzman Martinez, M. J. Acosta Falomir, A. P. Chischistz Condey; Mexico City/MX
DOI:
10.26044/ecr2019/C-0060
Conclusion
The correlation between Agatston Calcium Score and clinical cardiovascular assessment methods such as the Framingham risk score and the ACC/ AHA risk algorithm is mild.
It is important to consider the Agatston Calcium Score and the cardiovascular risk scores as complements of each other and not as substitutes.
Anthropometric measures such as body mass index and abdominal circumference have a very low correlation with the Agatston calcium score in female patients,
therefore,
we do not encourage further analysis.
In the case of our male patients we did not achieve a representative sample for a statistically significant result.
In the case of age,
it has a mild correlation with the Agatston calcium score,
nonetheless,
it was already noted in previous studies[4].
One major field of oportunity that must be exploited is the ability of calcium scoring to reclassify asymptomatic patients with intermediate risk scores determined by clinical cardiovascular risk tools,
in order to tailor statin drug therapy.
Our next step is to determine how many patients can be reclassified in higher or lower cardiovascular risk cathegories using the CAC-DRS and AHA recommendations published in 2018.
We are looking forward for our future results.